A new study found that the immunotherapy treatment worked against some types of cancers, allowing patients to avoid surgery ...

The FDA granted accelerated approval to the combination of avutometinib and defactinib (Avmapki Fakzynja Co-pack) for the ...

HealthCare has opened a new cancer center in partnership with New York City-based Memorial Sloan Kettering Cancer Center. Through the partnership, physicians at the Hartford HealthCare Fairfield ...

The post I Nearly Missed This Warning Sign Of Endometrial Cancer appeared first on Katie Couric Media.

State Sen. Tony Hwang, state Rep. Christine McCarthy Vahey, Fairfield First Selectman Bill Gerber were on hand for the opening ...

This event is supported by Pfizer, DSI and Regeneron.WASHINGTON, May 07, 2025 (GLOBE NEWSWIRE) -- OncLive®, the nation’s leading multimedia resource for oncology professionals and Pfizer (platinum ...

This new immunotherapy is particularly effective in several types of solid tumors, but it will take time to confirm its ...

This year, the event highlighted eight-year-old Emily Buck, who is undergoing treatment for T-cell acute lymphoblastic ...

According to the results of a new study in the New England Journal of Medicine, 92% of patients who took this drug were cancer-free after two years.

Join leading experts to discuss how we are ushering in a new era in bladder cancer care on May 28 virtually. Register now.

The FDA has granted accelerated approval to the combination therapy of avutometinib and defactinib (Avmapki Fakzynja Co-pack) ...